Haemonetics
HAE
$84.08
Share price
-0.67%
Change (1 day)
-2.88%
Change (1 year)
Categories
Haemonetics (HAE) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.23 B
According to Haemonetics's latest financial reports the company's total liabilities are $1.23 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Haemonetics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $1.11 B | 0.59% |
| 2022-03-31 | $1.11 B | 2.03% |
| 2021-03-31 | $1.08 B | 60.04% |
| 2020-03-31 | $0.68 B | 12.05% |
| 2019-03-31 | $0.60 B | 25.16% |
| 2018-03-31 | $0.48 B | -2.84% |
| 2017-03-31 | $0.49 B | -16.48% |
| 2016-03-31 | $0.59 B | -9.36% |
| 2015-03-31 | $0.65 B | -2.51% |
| 2014-03-31 | $0.67 B | -2.37% |
| 2013-03-31 | $0.69 B | 288.08% |
| 2012-03-31 | $0.17 B | 21.33% |
| 2011-03-31 | $0.14 B | -12.32% |
| 2010-03-31 | $0.16 B | 52.81% |
| 2009-03-31 | $0.10 B | -4.32% |
| 2008-03-31 | $0.11 B | 23.28% |
| 2007-03-31 | $93.08 M | -11.26% |
| 2006-03-31 | $0.10 B | -6.86% |
| 2005-03-31 | $0.11 B | -11.77% |
| 2004-03-31 | $0.12 B | -6.31% |
| 2003-03-31 | $0.13 B | 6.36% |
| 2002-03-31 | $0.12 B | -1.31% |
| 2001-03-31 | $0.12 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 8,150.53% | 🇺🇸 USA |
 Medtronic MDT | $38.84 B | 3,043.34% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $51.47 B | 4,065.57% | 🇺🇸 USA |
 Baxter BAX | $19.55 B | 1,482.43% | 🇺🇸 USA |
 Becton Dickinson BDX | $28.50 B | 2,207.24% | 🇺🇸 USA |
 Stryker Corporation SYK | $20.23 B | 1,537.22% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 434.49% | 🇺🇸 USA |
 Cerus CERS | $0.13 B | -88.75% | 🇺🇸 USA |